EAPIF
Price:
$3.59
Market Cap:
$288.31M
Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.
Industry
Medical - Devices
IPO Date
2022-05-20
Stock Exchange
OTC
Ticker
EAPIF
According to Euroapi S.A.’s latest financial reports and current stock price. The company's current ROE is -12.83%. This represents a change of 17.05% compared to the average of -10.97% of the last 4 quarters.
The mean historical ROE of Euroapi S.A. over the last ten years is -6.05%. The current -12.83% ROE has changed 112.32% with respect to the historical average. Over the past ten years (40 quarters), EAPIF's ROE was at its highest in in the June 2023 quarter at 5.26%. The ROE was at its lowest in in the December 2023 quarter at -27.22%.
Average
-6.05%
Median
-1.08%
Minimum
-20.45%
Maximum
0.25%
Discovering the peaks and valleys of Euroapi S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.41%
Maximum Annual ROE = 0.25%
Minimum Annual Increase = -359.31%
Minimum Annual ROE = -20.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | -13.28% | -35.06% |
| 2023 | -20.45% | 1.41% |
| 2022 | -1.35% | 68.72% |
| 2021 | -0.80% | 25.76% |
| 2020 | -0.64% | -359.31% |
The current ROE of Euroapi S.A. (EAPIF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.69%
5-year avg
-7.30%
10-year avg
-6.05%
Euroapi S.A.’s ROE is less than Ion Beam Applications S.A. (14.79%), less than Northwest Biotherapeutics, Inc. (92.80%), greater than 3-D Matrix, Ltd. (-129.53%), greater than BioPorto A/S (-133.40%), less than Clinuvel Pharmaceuticals Limited (15.79%), less than Kneat.com, Inc. (0.83%), greater than Immutep Limited (-38.87%), less than Lattice Biologics Ltd. (23.33%), less than CytoDyn Inc. (22.25%), greater than Cellectis S.A. (-49.81%),
| Company | ROE | Market cap |
|---|---|---|
| 14.79% | $388.71M | |
| 92.80% | $368.07M | |
| -129.53% | $214.45M | |
| -133.40% | $130.28M | |
| 15.79% | $377.94M | |
| 0.83% | $329.68M | |
| -38.87% | $264.95M | |
| 23.33% | $16.55K | |
| 22.25% | $407.81M | |
| -49.81% | $325.46M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Euroapi S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Euroapi S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Euroapi S.A.'s ROE?
How is the ROE calculated for Euroapi S.A. (EAPIF)?
What is the highest ROE for Euroapi S.A. (EAPIF)?
What is the 3-year average ROE for Euroapi S.A. (EAPIF)?
What is the 5-year average ROE for Euroapi S.A. (EAPIF)?
How does the current ROE for Euroapi S.A. (EAPIF) compare to its historical average?